Delivery Order SPE2DB20D9331-SPE2DB25FL1B2

Award Date 4/7/25
Potential Completion Date 4/28/25
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,081.20, is for the provision of the pharmaceutical product ZOSYN 4.5 GM/100 ML GALAXY BAG 100ML. The contract is part of a larger indefinite delivery contract (IDC) with DLA under the SPE2DB program, valued at up to $499,999,999, which runs through...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $1,078.70, is for the supply of a pharmaceutical product called ZOSYN 4.5 GM/100 ML GALAXY BAG 100ML. The delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,000.32, is for the delivery of ZOSYN 3.375 GM/50 ML GALAXY 50ML, a pharmaceutical product, to support the medical supply needs of military health facilities. The award is part of a larger Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,979.90 contract was issued by the Defense Logistics Agency (DLA) under the agency's SPE2DB program, which is a single-award indefinite delivery contract (IDC) valued at up to $499,999,999 to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of Department...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, with a ceiling value of $2,097.60, is for the delivery of the pharmaceutical product ZOSYN 4.5 GM/100 ML GALAXY BAG 100ML. This order is part of a larger indefinite-delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $2,000.64, is for the delivery of ZOSYN 3.375 GM/50 ML GALAXY 50ML, a pharmaceutical product. The contract is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,541.16 contract is for the delivery of ZOSYN 3.375 GM/50 ML GALAXY 50ML pharmaceutical products to support the recurring medical supply needs of military health facilities. The delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,486.40 contract is for the delivery of ZOSYN 4.5 GM/100 ML GALAXY BAG 100ML, a pharmaceutical product, with a performance period ending on July 9, 2025. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The $1,000.32 order is for the supply of the pharmaceutical product "ZOSYN 3.375 GM/50 ML GALAXY 50ML" with a performance period through May 6, 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA, valued at $499,999,999 and valid through November 2026. This IDC...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,659.50 contract is for the delivery of ZOSYN 3.375 GM/50 ML GALAXY 50ML, a branded pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This IDC...
  • SPE2DB20D9331
    Indefinite Delivery Contract
  • SPE2DB20D9331-SPE2DB25FL1B2
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at $2,072.00, is for the delivery of ZOSYN 4.5 GM/100 ML GALAXY BAG 100ML, a pharmaceutical product, to support the medical supply needs of military health facilities.

The award is part of a larger Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. The contract does not have a set-aside designation.

Generated 7/7/25, 1:25 PM